# Pharmacokinetics of Mitiglinide and Metformin in Free Combination and Fixed-dose Combination in Healthy Male Subjects.

> **NCT01443221** · PHASE1 · COMPLETED · sponsor: **JW Pharmaceutical** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** mitiglinide and metformin
- **DRUG:** mitiglinide and metformin

## Key facts

- **NCT ID:** NCT01443221
- **Lead sponsor:** JW Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2011-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01443221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01443221, "Pharmacokinetics of Mitiglinide and Metformin in Free Combination and Fixed-dose Combination in Healthy Male Subjects.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01443221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*